SOC Telemed
clinical and financial benefits for our customers | SOC Telemed
Company
Deck Type
Deck date
January 2022
Slide
17 of 27
Similar slides by SOC Telemed
See diffirences between slides (animation)
Investor Day
September 2020
clinical and financial benefits for our clients a | SOC Telemed
Related slides by other companies
Recursion Pharmaceuticals
Investor Day
January 2023
clinical patient population easily identifiable autosomal dominant tumor predisposition syndrome caused by a mutation in the gene classic mutation hundreds to thousands of polyps in colon and upper tract manifestations desmoid tumors likelihood of developing cancer before age if untreated disease overview familial adenomatous polyposis | Recursion Pharmaceuticals
Recursion Pharmaceuticals
Investor Day
January 2023
clinical disease overview difficile infection | Recursion Pharmaceuticals
Chimerix
Results
March 2022
treatment post infection protected mice from body weight loss and clinical symptoms of disease | Chimerix
MaxCyte
Results
November 2023
enables next generation cell therapies across a variety of diseases | MaxCyte
Other recent decks by SOC Telemed
See all presentations (2 decks)
Investor Day
September 2020
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights